News for Suven Life Sciences Limited (SUVEN.NS)

Anthem Biosciences IPO priced at ₹530-₹570, valued at ₹31,800 crore, with no funds going to the company.

Anthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True North.

Suven Life Sciences' Ropanicant shows promise for MDD treatment, with positive Phase 2a results and plans for Phase 2b study.

Her biggest chunk of wealth is derived from the sale of a stake in a pharma company.

The global Carglumic Acid market is anticipated to grow from USD 138.27 million to USD 281.81 million in 10 years. The market is likely to experience...

Suven Life Sciences Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 30.6 million compared...

Based on the OI percentage, 81 stocks were on the short-covering list. These include Indraprastha Gas, Britannia Industries, Dr Lal PathLabs, Mahanagar Gas, and Maruti Suzuki India.

Continuous foreign fund outflows and weak trend in Asian and European markets also played spoilsport for the domestic markets

Suven Life Sciences announces two poster presentations including patient baseline characteristics and demographics from the phase-2 Proof of Concept study on samelisant at... | June 3, 2023

Based on the OI percentage, 79 stocks were on the short-covering list. These included Escorts, Shriram Finance, National Aluminium Company, Bharat Forge, and Vedanta.

The BSE midcap and smallcap indices end with marginal losses.

Stocks in news: Infosys, HCL Tech, Power Grid, Tata Power, BHEL, Inox Leisure and more

Read more about Stocks to Watch: L&T, Vedanta, NTPC, MCX, Dr.Reddy's, CBI, AU SFB, Textiles on Business Standard. BPCL, DLF, Dwarikesh Sugar, Exide, GIC Housing, HDIL, HPCL, IOC, Jindal Saw, KEC Intl, KPIT Tech, Krsnaa Diagnostics, SCI, Sun Pharma, Suven Life, Tata Motors and UCO Bank in focus ahead of Q3 results

If bulls manage to defend 17,100 levels in next session and puts it beyond 17,373 levels then eventually the consolidation zone can remain between 17,600 to 16,900 levels, says Mazhar Mohammad of ChartviewIndia.

Trends on SGX Nifty indicate a cautious opening for the index in India with a 11-points gain.

Stocks In the News: Check out the companies making the biggest headlines before the opening bell.

Considering overbought nature along with narrow market pariticipation, Mazhar Mohammad of Chartviewindia.in advised traders to book profits if index slips below 16,480 levels.